Why We Recommend and Use “The R.G.C.C. Cancer Test “

We have been using this test for about 10.5 years. We were the first clinic in the US and Canada to start looking at a better more Personalized Patient-Centered Cancer Care to help those with cancer. To date we have personally ordered over >700 tests. This has been in place in Europe for over 10 years. This is not “The Greece Cancer Cure” from Dr. Hariton-Tzannis Alivizatos of Athens, Greece. We do not profess to cure cancer. Over the last 10+ years this test has emerged to be one of the most accurate and complete test of its kind we have seen to date. The test is performed in Greece by Ioannis Papasotiriou, M.D., PhD, medical director of RGCC-Ltd. It was good in the beginning and has consistently improved over the years to a great test, in my opinion and the opinion of many other physicians throughout the world. The use of a simple blood sample with RGCC-Ltd works with ALL cancers (solid tumors, blood cancers, sarcomas, etc..) except brain and central nervous system primary tumors (glioblastomas, astrocytoma, meningioma etc..), RGCC Labs can still work with these cancers when provided with a small, live tissue sample from the tumor. The field of oncology has become highly competitive over the past 2-3 years, due to a beginning paradigm shift, based on long standing lack of good predictable results. Mass General, Sloan Kettering, University of Texas M.D. Anderson Cancer Center in Houston, and Dana-Faber Cancer Institute of Boston have all started using and developing a similar test in the last 2 years. They estimated it may start being used in about 5-9 years. At this point, none of these centers or any others we have looked at can do (or will do) what RGCC-labs of Greece does from only ~2 tablespoon of your blood. Now that is phenomenal use of modern day technology. We know that cancer has been metastasizing [spreading and with a vengeance] in most all cancer patients for many, many years with little or no change. Up until recently no one knew for sure how or why this happened, just that it happened with great frequency. Now, many scientist throughout the world and saying, it is due to the circulating tumor and cancer stem cells (CTC’s/CSC’s). This is rapidly becoming the focus of much cancer research, how to stop these peripheral CTC’s and CSC’s from causing metastatic tumors which is responsible for at least 90% of all cancer related deaths. Furthermore, the CTC’s and CSC’s are suspected by many scientist to be the cause of almost if not all the metastasizes that do occur. With this new information what should be one of the main targets by oncologists? Not just the tumor (as it is now) more importantly the circulating CTC’s and CSC’s from each individual, these are the real trouble makers. The primary cancer tumor is bad enough, but the CTC’s and CSC’s are the real problem. These cells are responsible for the metastasis and return of this chronic, systemic disease. In the last 42 years, well into the trillions of dollars have been spent on cancer research and treatment since the war on cancer was declared in 1971. The overall results of these efforts, time and money adds up to only ~2.1-7.5% increase in the 5 yr. survival rate (see page 5, #1 for source and details). All this time, money spent, patient suffering and death, in my opinion, is not something one would be proud of and definitely not a good return on your many billion or trillion dollars of investment. The personalized cancer test from RGCC-Labs in Greece is known as an ex vivo test. Ex vivo (Latin: “out of the living”) means that which takes place outside an organism. In science, ex vivo refers to experimentations or measurements done in or on tissues (or in this case CTC’s and CSC’s) in an artificial environment outside the organism with the minimum alteration of natural conditions. Ex vivo conditions allow experimentation under more controlled conditions than is possible for in-vivo experiments (in the intact organism), at the expense of altering the “natural” environment. RGCC has developed a way to not change any of the genetics (genotype and phenotype) or epigenetic expression and equally important to not change the epigenetics of the CTC’s and CSC’s this is very important.

Share this Post!
About the Author : Dr. Bill Deagle MD